Latest Market Engagement News

Papyrus Australia has taken a significant step towards commercialisation with a $4.2 million supply contract and the near completion of its Adelaide Rapid Prototyping and R&D Facility.

Optiscan Imaging Ltd has made significant strides in clinical studies and regulatory readiness, partnering with Australian Clinical Labs and launching new cancer imaging trials as it prepares for multiple FDA submissions in 2026.

Jade Gas Holdings reported continuous gas production from two wells at its Red Lake coal bed methane project in Mongolia during Q4 2025, confirming commercial viability with exceptionally high methane purity. The company also secured a $70 million non-binding LOI and appointed a new CEO to drive development.

Sarytogan Graphite Limited reports robust drilling results and key contract awards, progressing its flagship graphite project while advancing copper exploration and securing critical funding.

Wrkr Ltd has transitioned from development to deployment, launching key products and acquiring PaidRight to expand its payroll compliance offerings ahead of new legislation.

Group One Capital Limited has reported a remarkable 246% increase in revenue for the half-year ending December 2025, alongside expanding its structured funding facilities beyond $240 million through its subsidiary FSU Capital.

D3 Energy has reported encouraging progress in its South African helium and methane operations, highlighted by improved gas flow rates from the Nooitgedacht Major well and an upgraded US OTCQX listing to broaden investor reach.

CurveBeam AI reported steady device orders alongside a $4 million milestone payment from its China commercialisation deal, while progressing FDA clearance and robotic surgery system validation.

Li-S Energy has made significant strides in Q4 2025, securing a major government grant, forging key defence partnerships, and commissioning Australia’s first lithium foil production line.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

Athena Resources has reported a maiden inferred resource estimate for its Byro South Magnetite Project, boosting the global Byro resource by 160%. The company also strengthened its leadership with the appointment of former WA Minister Alannah MacTiernan.

Cleo Diagnostics has broadened its U.S. market opportunity to around 2 million women annually and is on track to complete its pivotal clinical trial early this year, supported by a $5 million capital raise and regulatory progress.